Citadel Advisors
LONA

Citadel Advisors’s LeonaBio Inc LONA Stock Holding History

Citadel Advisors’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-440
Closed -$1.25K – 12466
2025
Q1 		$1.25K Buy
440
+360
+450% +$1.59K ﹤0.01% 14155
2024
Q4 		$469 Sell
80
-6,720
-99% -$37.9K ﹤0.01% 14319
2024
Q3 		$30.3K Buy
6,800
+5,510
+427% +$129K ﹤0.01% 12427
2024
Q2 		$34.2K Buy
1,290
+740
+135% +$17.5K ﹤0.01% 12146
2024
Q1 		$15.1K Buy
550
+40
+8% +$1.27K ﹤0.01% 13207
2023
Q4 		$12.4K Sell
510
-470
-48% -$8.34K ﹤0.01% 12994
2023
Q3 		$19.8K Sell
980
-2,820
-74% -$72.2K ﹤0.01% 12638
2023
Q2 		$112K Sell
3,800
-280
-7% -$7.98K ﹤0.01% 10753
2023
Q1 		$102K Sell
4,080
-240
-6% -$7.73K ﹤0.01% 11234
2022
Q4 		$137K Buy
4,320
+160
+4% +$5.04K ﹤0.01% 10745
2022
Q3 		$124K Sell
4,160
-31,890
-88% -$1.1M ﹤0.01% 10903
2022
Q2 		$1.1M Buy
36,050
+17,130
+91% +$1.57M ﹤0.01% 6809
2022
Q1 		$2.55M Sell
18,920
-40
-0.2% -$4.22K ﹤0.01% 5547
2021
Q4 		$2.47M Buy
18,960
+11,810
+165% +$1.49M ﹤0.01% 5760
2021
Q3 		$671K Buy
7,150
+2,180
+44% +$222K ﹤0.01% 9171
2021
Q2 		$509K Buy
+4,970
New +$868K ﹤0.01% 10020

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
SSC
Spruce Street Capital New York $416M AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors's LONA Position: Q4 2025 in Review

Citadel Advisors sold out of LeonaBio Inc (LONA) in Q4 2025, closing a stake of 33,987 shares — an estimated $141K sold.

Citadel Advisors first reported a position in LONA in Q3 2020 and held it in 19 quarters. The position peaked at $39.8M in Q4 2020. 42 funds tracked by Wall St. Rank hold LONA as of Q4 2025.

  • Citadel Advisors reported no remaining LeonaBio Inc position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 33,987 LeonaBio Inc shares in Q4 2025, an estimated $141K.
  • Citadel Advisors first reported a position in LeonaBio Inc in Q3 2020 and held it in 19 quarters.
  • Citadel Advisors's LeonaBio Inc position peaked at $39.8M in Q4 2020.
  • 42 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.